Table 4

Clinical outcomes

Overallhs-TnI −/BNP −hs-TnI −/BNP +hs-TnI +/BNP −hs-TnI +/BNP +OR versus hs-TnI −/BNP −
hs-TnI +/BNP −hs-TnI −/BNP +hs-TnI +/BNP +
Mortality92/397 (23.2)13/208 (6.3)20/59 (33.9)9/40 (22.5)50/90 (55.6)4.35 (1.72–11.04)7.69 (3.53–16.75)18.75 (9.32–37.71)
ICU admission65/397 (16.4)24/208 (11.5)13/59 (22.0)11/40 (27.5)17/90 (18.9)2.90 (1.29–6.56)2.16 (1.03–4.58)1.79 (0.91–3.52)
ARDS86/397 (21.2)31/208 (14.9)19/59 (32.2)14/40 (35.0)22/90 (24.4)3.07 (1.44–6.53)2.71 (1.39–5.28)1.84 (1.00–3.41)
Shock10/397 (2.5)2/208 (1.0)0/59 (0)3/40 (7.5)5/90 (5.6)8.35 (1.35–51.70)6.06 (1.15–31.84)
Discharge305/397 (76.8)195/208 (93.7)39/59 (66.1)31/40 (77.5)40/90 (44.4)0.23 (0.09–0.59)0.13 (0.06–0.28)0.05 (0.03–0.11)
  • ARDS, acute respiratory distress syndrome; BNP, B-type natriuretic peptide; hs-TnI, high-sensitivity troponin I; ICU, intensive care unit.